Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$37,773,651
+$10,229,300 QoQ
Shares Held
31,493
+5.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.50%
of 13F equity value
Holder Rank
#623
of 4,604 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST CITIZENS BANK & TRUST CO holds $87,047,230 across 11 Drug Manufacturers - General names. LLY ranks #1 (43.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
31,493 | $37,773,651 | |
| 2 | ABBV |
AbbVie Inc.
|
43,514 | $10,949,862 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
73,799 | $9,323,765 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,055 | $8,231,067 | |
| 5 | JNJ |
Johnson & Johnson
|
30,811 | $7,825,069 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
94,434 | $5,441,286 | |
| 7 | AMGN |
Amgen Inc
|
9,717 | $3,518,719 | |
| 8 | PFE |
Pfizer Inc
|
79,991 | $1,926,182 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,773,651 | 31,493 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $27,544,351 | 29,947 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $31,491,350 | 29,303 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $18,795,742 | 24,634 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $12,092,848 | 15,513 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $11,340,569 | 13,731 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $10,417,368 | 13,494 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $11,656,311 | 13,157 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $7,983,639 | 8,818 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $6,900,505 | 8,870 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $2,873,795 | 4,930 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $2,356,388 | 4,387 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $2,129,168 | 4,540 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,460,908 | 4,254 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,707,740 | 4,668 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,821,430 | 5,633 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $2,032,596 | 6,269 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $1,135,456 | 3,965 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,088,582 | 3,941 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $753,684 | 3,262 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,465,025 | 6,383 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $1,277,661 | 6,839 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,173,269 | 6,949 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,203,846 | 8,133 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $1,589,097 | 9,679 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $482,883 | 3,481 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||